Pluri Inc. Excess Stock, Shares Issued
Pluri Inc. (PLUR) had Excess Stock, Shares Issued of 1.02 million shares as of 2022-12-27, per its 10-K filed 2024-09-18.
Discontinued › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure
us-gaap:ExcessStockSharesIssued · last filed 2024-09-18
- 2022-12-27: Excess Stock, Shares Issued 1.02M shares; Excess Stock, Shares Issued as first filed 8.16M shares.
- 2022-12-13: Excess Stock, Shares Issued 1.02M shares; Excess Stock, Shares Issued as first filed 8.16M shares.
- 2022-02-24: Excess Stock, Shares Issued 187.50K shares.
- 2022-01-05: Excess Stock, Shares Issued 187.50K shares.
| Period end | Excess Stock, Shares Issued | Excess Stock, Shares Issued as first filed |
|---|---|---|
| 2022-12-27 | 1.02M shares 10-K · filed 2024-09-18 | 8.16M shares 10-Q · filed 2024-02-12 |
| 2022-12-13 | 1.02M shares 10-K · filed 2024-09-18 | 8.16M shares 10-Q · filed 2024-02-12 |
| 2022-02-24 | 187.50K shares 10-Q · filed 2023-02-13 | |
| 2022-01-05 | 187.50K shares 10-K · filed 2024-09-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |